Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07741214

Low Power HOLEP Versus TURP

Patients with obstructed flow due to BPH will be enrolled into 2 groups, group will undergo TURP and the other group will undergo Low power HOLEP

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

50 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Mohamed Fawzy Salman

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • mens with LUTS due to obstructed prostate

Exclusion criteria

  • stone bladder bladder cancer prostate cancer

Treatment and study plan

low power HOLEP

Procedure

Patients who will undergo transurethral resection of the prostate

TURP

Procedure

Patients who will undergo transurethral resection of the prostate

Primary outcomes

  1. Change in The International Prostate Symptom Score (IPSS)

    Time frame: 6 months

    The International Prostate Symptom Score (IPSS) can be utilized to measure the severity of lower urinary tract symptoms.

    It is a validated, reproducible scoring system to assess disease severity and response to therapy.

    The IPSS is made up of 7 questions related to voiding symptoms. A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms.

Sponsors and collaborators

Lead sponsor

Al-Azhar University

Other

Registry information

Official study title

Low Power HOLEP Versus TURP in Management of BPH

Acronym: HOLEP vs TURP

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 3, 2026
Registry last updated
Aug 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.